Studies of the alternate pathway in chelated serum
- PMID: 805816
Studies of the alternate pathway in chelated serum
Abstract
Activation of the alternate pathway in chelated serum by cobra venom factor (Co F), endotoxin of Escherichia coli, inulin, and zymosan was studied by immunoelectroprhoresis, radial immunodiffusion, and complement fixation tests. In serum chelated by 10 mM EGTA and 10 mM MgCl-2 (10 mM MgEGTA) activation by the classical pathway was blocked, but activation of C3PA and C3 occurred normally. By radial immunodiffusion assay, consumption of C3 and properdin was demonstrated to be similar to consumption in nonchelated sera. By immunoelectrophoresis, C3PA and C3 were shown to be activated by CoF in serum chelated with 6 mM but not with 10 mM EGTA without added Mg++. Inulin and endotoxin did not result in activation of either C3PA or C3, while C3PA but not C3 was activated by zymosan in the presence of 10 mM EGTA without Mg++ added. Consumption of properdin and C3, measured by radial immunodiffusion, was inhibited by 6 to 10 mM EGTA following activation by inulin, but not following activation by zymosan. The usefulness of 10 mM MgEGTA-chelated serum for the selective investigation of the alternate pathway in chemotaxis was demonstrated.
Similar articles
-
The effect of anticomplementary substances on properdin in normal and C2-deficient sera.Clin Exp Immunol. 1975 Mar;19(3):435-44. Clin Exp Immunol. 1975. PMID: 1204244 Free PMC article.
-
Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.Infect Immun. 1975 Jun;11(6):1235-43. doi: 10.1128/iai.11.6.1235-1243.1975. Infect Immun. 1975. PMID: 806523 Free PMC article.
-
Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.Jpn J Exp Med. 1980 Feb;50(1):13-21. Jpn J Exp Med. 1980. PMID: 6770130
-
Activation, activities and pharmacologically active products of complement.Pharmacol Rev. 1974 Jun;26(2):125-69. Pharmacol Rev. 1974. PMID: 4609350 Review. No abstract available.
-
Inhibition of complement-derived enzymes.Ann N Y Acad Sci. 1975 Jun 13;256:441-50. doi: 10.1111/j.1749-6632.1975.tb36070.x. Ann N Y Acad Sci. 1975. PMID: 808993 Review. No abstract available.
Cited by
-
TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity.Infect Immun. 1993 Aug;61(8):3578-82. doi: 10.1128/iai.61.8.3578-3582.1993. Infect Immun. 1993. PMID: 8392976 Free PMC article.
-
Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.Infect Immun. 1979 Jul;25(1):293-8. doi: 10.1128/iai.25.1.293-298.1979. Infect Immun. 1979. PMID: 383617 Free PMC article.
-
Effects of trospectomycin on serum sensitivity of Escherichia coli UC 9451.Antimicrob Agents Chemother. 1990 Nov;34(11):2086-92. doi: 10.1128/AAC.34.11.2086. Antimicrob Agents Chemother. 1990. PMID: 2149919 Free PMC article.
-
Antibody-independent binding of complement component C1q by Legionella pneumophila.Infect Immun. 1995 Dec;63(12):4939-43. doi: 10.1128/iai.63.12.4939-4943.1995. Infect Immun. 1995. PMID: 7591161 Free PMC article.
-
Chemotaxigenesis by cell surface components of Staphylococcus aureus.Infect Immun. 1979 Oct;26(1):57-63. doi: 10.1128/iai.26.1.57-63.1979. Infect Immun. 1979. PMID: 500215 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous